Abaloparatide is an Effective Treatment Option for Postmenopausal Osteoporosis: Review of the Number Needed to Treat Compared with Teriparatide
Crossref DOI link:
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Williams, Gregory C.
Fitzpatrick, Lorraine A.
Lewiecki, E. Michael
Funding for this research was provided by:
Radius Health, Inc.
Text and Data Mining valid from 2018-06-27